Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
|
|
Disc Medicine, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 10/10/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 09/29/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 08/22/2023 |
4
| Savage William Jacob (Chief Medical Officer) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $2.65, valued at
$8k
|
|
| 08/17/2023 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 72,931 shares
@ $52.4, valued at
$3.8M
|
|
| 08/17/2023 |
3/A
| Bitterman Kevin (Director) has filed a Form 3/A on Disc Medicine, Inc. |
| 08/16/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 75,000 shares
@ $52, valued at
$3.9M
Sold 98,000 shares
@ $53, valued at
$5.2M
Sold 2,000 shares
@ $54.8, valued at
$109.6k
Sold 111,069 shares
@ $52.4, valued at
$5.8M
Sold 72,931 shares
@ $52.4, valued at
$3.8M
|
|
| 08/16/2023 |
4
| Savage William Jacob (Chief Medical Officer) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 3,708 shares
@ $52.2707, valued at
$193.8k
Sold 2,125 shares
@ $53.2589, valued at
$113.2k
Sold 1,839 shares
@ $53.9642, valued at
$99.2k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Savage William Jacob (Chief Medical Officer) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 3,200 shares
@ $48.9003, valued at
$156.5k
Sold 3,588 shares
@ $50.218, valued at
$180.2k
Sold 1,481 shares
@ $50.9122, valued at
$75.4k
|
|
| 08/11/2023 |
8-K
| Quarterly results |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Bryce Joanne (CFO) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 3,067 shares
@ $49.6292, valued at
$152.2k
Sold 1,454 shares
@ $50.4954, valued at
$73.4k
Exercised 4,521 options to buy
@ $1.01, valued at
$4.6k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| MacDonald Brian Richard (Chief Innovation Officer) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 2,247 shares
@ $49.243, valued at
$110.6k
Sold 1,900 shares
@ $50.3844, valued at
$95.7k
Sold 953 shares
@ $50.8032, valued at
$48.4k
Sold 736 shares
@ $44.3698, valued at
$32.7k
Sold 2,230 shares
@ $45.4946, valued at
$101.5k
Sold 1,934 shares
@ $46.511, valued at
$90k
Sold 200 shares
@ $47.24, valued at
$9.4k
Sold 2,923 shares
@ $44.8518, valued at
$131.1k
Sold 1,401 shares
@ $45.4506, valued at
$63.7k
Sold 600 shares
@ $46.7633, valued at
$28.1k
|
|
| 06/30/2023 |
4
| Bryce Joanne (CFO) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 4,808 shares
@ $49.3015, valued at
$237k
Sold 4,905 shares
@ $50.4957, valued at
$247.7k
Sold 359 shares
@ $51.228, valued at
$18.4k
Exercised 7,880 options to buy
@ $1.01, valued at
$8k
|
|
| 06/30/2023 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.2% stake in Disc Medicine, Inc. |
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| Savage William Jacob (Chief Medical Officer) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 1,520 shares
@ $49.1991, valued at
$74.8k
Sold 1,300 shares
@ $50.003, valued at
$65k
Sold 1,564 shares
@ $50.7207, valued at
$79.3k
|
|
| 06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
SC 13G/A
| Novo Holdings A/S reports a 4.8% stake in Disc Medicine, Inc. |
| 06/28/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 1,250,000 shares
@ $46.1, valued at
$57.6M
|
|
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Underwriting Agreement, by and among the Company and Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, and BMO Capital Markets Corp., as representatives of the several underwriters listed on Schedule A thereto",
"Form of Pre-Funded Warrant",
"Opinion of Goodwin Procter LLP regarding the issue of Common Stock, Pre-Funded Warrants and Common Stock issuable upon exercise of the Pre-Funded Warrants being registered",
"Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants",
"Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants" |
|
| 06/12/2023 |
8-K
| Other Events Interactive Data |
| 06/12/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/09/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,136 options to buy
@ $45.69, valued at
$326k
|
|
|
|
|